Who Attends

Interdisciplinary & Interconnected

More than 1,200 attendees are expected to attend the 2016 World Stem Cell Summit & RegMed Capital Conference from 40 countries+. Prominent industry leaders, scientists, clinicians, venture capitalists, angel investors, philanthropists, regulators, policymakers, patient advocates, economic development officers, experts in law and ethics and others gather together to advance our field.  

Who Attends the World Stem Cell Summit & RegMed Capital Confernce:

2010 World Stem Cell Summit AudienceAcademic & Government Institutions
Cell therapy, gene therapy & tissue engineering programs
Clinical centers & hospitals
Funding agencies
Policy makers, government leaders
Stem cell network leaders
Technology transfer staff
Students & post-docs

Therapeutic and Enabling Products & Technology
Academic investigators
Biotechnology and pharmaceutical companies
Cord blood banks
Cell therapy companies
Gene therapy companies
Immunotherapy companies
Medical device companies
Platform technology, equipment manufacturers & suppliers
Reagents & materials suppliers
Tissue engineering companies
Data companies

Contract Service Providers
Contract manufacturing organizations (CMO) – GMP, GTP
Contract research organizations (CRO)
Contract testing laboratories
Law firms
Tissue procurement organizations, cell collection services
Transportation & logistics services, cell banking services

Investors, Analysts & Business Developers

Angel investors
Venture capitalists/private equity
Family funds
Institutional investors
Individual investors
Financial & market analysts
C-Suite executives
Board members
Insurance companies
Law firms
National investment departments
Technology transfer staff

Regulatory & Policy Agencies
IRB, ESCRO & SCRO committee members
Law firms
National & international regulators – FDA, EMA, etc

Patient Advocacy Organizations, Patient Advocates & Clinicians
Advocacy organizations
Medical philanthropies
Patients & patients’ families

Science and Medical Journalists